Introduction
Using a human fetal brain-derived protein macroarray in a modified SEREX 1 approach we identified paratarg-7 as the target of 15% of IgA or IgG paraproteins 2 and 11% of IgM paraproteins 3 . All patients with paratarg-7 specific paraproteins are carriers of a hyperphosphorylated version of the protein (pP-7) and this hyperphosphorylation is inherited in a dominant fashion 2;4 . pP-7 carrier state is associated with an increased risk to develop IgA/IgG-MGUS/MM (odds ratio: 7.9) 2 and IgM-MGUS (odds ratio 6.5) 3 . Since pP-7 is the first molecularly defined risk factor for any hematological neoplasm known to date 2;3 , we set out to define the antigenic targets of paraproteins from affected members of families with familial MGUS/MM.
Methods

Patients and controls
This study was approved by the local ethical review board ("Ethikkommission der Ärztekammer des Saarlandes") and conducted according to the Declaration of Helsinki. Peripheral blood and serum samples from 31 healthy and 10 affected members of 4 families with familial MGUS/MM were collected after obtaining written informed consent.
Serum screening on high-density protein arrays, immunoblot analyses, absorption studies, isoelectric focusing (IEF), and phosphatase treatment of paraprotein targets These were performed as described before 2;5 . Absorption studies using His 6 -tagged paratarg-8 protein or erythrocyte lysates were performed as described before for paratarg-7 
Results / Discussion
Four families with ≥ 2 cases of MGUS/MM were included in this study. No antigenic target was identified for the paraproteins from a brother and a sister of the first family, both affected by MM. Two sisters diagnosed with MGUS in the second family whose pedigree had been described before 2 and two siblings with MM in the third family (S Fig. 1 ) all had an anti-paratarg-7 specific paraprotein and were carriers of pP-7.
Identification and characterization of paratarg-8
The paraproteins from 2 MGUS and 2 MM patients of the fourth family ( To investigate the prevalence of paraproteins with paratarg-8 specificity, 300 paraproteincontaining sera were tested for reactivity with paratarg-8 by ELISA. Of these, only one reacted with paratarg-8 (titer 1:10 7 ). Sequence analysis of paratarg-8 derived from patients with a
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From paraprotein-8 specific paraprotein and healthy controls excluded mutations or polymorphisms as a cause of the autoimmunogenicity of paratarg-8. All lysates from patients with a paraprotein with anti-paratarg-8 or non-paratarg-8 specificity and healthy controls showed identical bands in the Western blots (data not shown). However, erythrocyte lysates from healthy controls and from patients with a paratarg-8 specific paraprotein migrated differently in the IEF (S Fig. 3) . After phosphatase treatment all lysates showed identical bands in the IEF, regardless of whether they were derived from healthy controls, from patients having a paraprotein with specificity for paratarg-8, or from patients with a paraprotein that did not bind to paratarg-8. Differential 
Phosphorlyation state of other autoantigenic targets of paraproteins
All other molecularly defined autoantigenic targets of paraproteins from sporadic, non-familial cases of MGUS/MM identified by our group to date, where cells from the respective patients were available, were tested by IEF before and after phosphatase treatment (Tab. 1). In all these cases the patients´ paraprotein target was hyperphosphorylated compared to normal controls (S Fig. 4 ). 
org From
Hyperphosphorylated Paratarg-7 p. 6 Paraproteins from patients of families with multiple cases of MGUS/MM are directed against the same autoantigen: while no target could be identified for the paraproteins from 2 siblings of family #1, the paraproteins from each 2 affected family members of family #2 and family #3 (S Fig. 1) , respectively, recognized paratarg-7, and the paraproteins from family #4 (Fig. 1) reacted with paratarg-8 . The second intriguing finding of our study is that the autoantigens detected by the autologous paraproteins were hyperphosphorylated in the respective patients compared to normal controls in all (8/8) cases where this analysis was possible. The fact that all autoantigenic targets (and possible stimuli) of paraproteins molecularly defined to date are hyperphosphorylated suggests that hyperphosphorylation might be a general mechanism underlying the pathogenesis of MGUS/MM that is operative in many more cases than those with the 8 autoantigenic paraprotein targets described in this study. The elucidation of how this mechanism induces the clonal evolution of a B-cell clone with specificity for the respective autoantigen as well as the question why some carriers of hyperphosphorlyated antigens develop MGUS/MM while others do not, can now be addressed using specific molecular tools.
There have been a number of studies of familial multiple myeloma, implicating both environmental and inherited factors [7] [8] [9] [10] [11] , but results have been inconsistent 12 . pP-7 and pP-8 are the first molecularly characterized structures that provide a plausible explanation for the familial clustering of cases of MGUS/MM, at least in cases with a paratarg-7 (2 families) or paratarg-8
(one family to date) specific paraprotein. While a molecular mimicry between these autoantigens and infectious agents can not be definitely excluded, this mechanisms is highly unlikely for two reasons: first, a data bank search comparing the autoantigenic targets with sequences from bacteria or viruses did not reveal significant homologies (data not shown); 2 nd , it would not explain why only the hyperphosphorylated, but not the wildtype protein acts as an autoantigen.
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